Page 5 - Diaspective Vision

Imprint and data protection

Written by Philip Wahl at October 8, 2020. Published in Company.

Imprint

Diaspective Vision GmbH
Strandstr. 15
18233 Am Salzhaff-Pepelow
Germany

+49 38294 1667-60
office@diaspective-vision.com

Managing Director: Amadeus Holmer
Registered office/ Register court: Rostock Local Court Register number: HRB 13203
Sales tax identification number: DE300302038
Responsible for content: Amadeus Holmer

Website

Tom Greis BK
tomgreis.com

Copyright

Creative services on our pages are subject to copyright. We thank the following photographers for their contributions: J. C. Gellidon (Unsplash), Piron Guillaume (Unsplash), absolutvision (Unsplash), Stefan Straube (Leipzig University Hospital). The following fonts are used on the website: GT Walsheim (Grilli Type), Inter (Google Fonts).

Liability for contents

The contents of our pages were created with the utmost care. However, we cannot guarantee the accuracy, completeness and timeliness of the content. As a service provider, we are responsible for our own content on these pages in accordance with § 7 paragraph 1 TMG under the general laws. According to §§ 8 to 10 TMG we are not obligated to monitor transmitted or stored information or to investigate circumstances that indicate illegal activity. Obligations to remove or block the use of information according to general laws remain unaffected by this. However, liability in this respect is only possible from the point in time at which a concrete infringement of the law becomes known. If we become aware of any such infringements, we will remove the relevant content immediately.

Liability for links

Our offer contains links to external websites of third parties, on whose contents we have no influence. Therefore, we cannot assume any liability for these external contents. The respective provider or operator of the pages is always responsible for the content of the linked pages. The linked pages were checked for possible legal violations at the time of linking. Illegal contents were not recognizable at the time of linking. However, a permanent control of the contents of the linked pages is not reasonable without concrete evidence of a violation of the law. If we become aware of any infringements, we will remove such links immediately.

Copyright

The contents and works created by the site operators on these pages are subject to German copyright law. Contributions of third parties are marked as such. Duplication, processing, distribution, or any form of commercialization of such material beyond the scope of the copyright law shall require the prior written consent of its respective author or creator. Downloads and copies of this site are only permitted for private, non-commercial use. The operators of these pages always endeavour to respect the copyrights of others or to use their own works or works in the public domain. Should you nevertheless become aware of a copyright infringement, please inform us accordingly. If we become aware of any infringements, we will remove such content immediately.

About us

Written by Philip Wahl at October 2, 2020. Published in Company.

As a young medical technology company, Diaspective Vision GmbH has been an innovation driver in the field of spectral camera solutions for medical applications since 2015.

Diaspective Vision develops and produces high-quality hyperspectral and multispectral camera systems for use in various areas of medicine. With our application-oriented product solutions, we provide competent and flexible support for both clinical and preclinical applications.

We are firmly convinced that Medical Spectral Imaging will decisively change medicine. Our products will provide users with new diagnosis-supporting possibilities, which can contribute to faster and better decisions in everyday clinical practice. The focus of our daily work is to improve the outcome for patients, clinicians and the entire healthcare system!

From the very beginning, the entire DV team has relied on close cooperation with clinical partners from various disciplines in order to develop practical and application-oriented systems.

Team

At our site in Am Salzhaff, Diaspective Vision GmbH employs staff in the areas of research and development, quality management, regulatory affairs, product management, production and administration.

You can reach us at +49 38294 1667-60 and at office@diaspective-vision.com.

Milestones

August 2023 Successful completion of the MDR certification process.

July 2021 The first prototype MALYNA® (multispectral camera) is delivered to a cooperation partner.

May 2021 Three new products are registered as medical devices - TIVITA® 2.0, TIVITA® Mini and TIVITA® Mobile.

October 2020 The self-developed, broadband LED illumination source is shown to be viable for hyperspectral applications. This lays the foundation for the follow-up product of the TIVITA® Tissue, the TIVITA® 2.0, and a proprietary illumination source for endoscopic applications.

September 2020 A study from Leipzig shows equivalence of clinical outcomes when using HSI and ICG.

January 2020 The second company building, the "Kegelrobbe", is occupied. Editorials are published in two prestigious journals "Der Chirurg" and "Der Onkologe" dealing with the topics "spectral imaging" and our TIVITA®.

June 2019 The first miniaturized HSI cameras are tested to pave the way for endoscopic applications.

March 2019 Diaspective Vision GmbH welcomes Karl Storz SE § Co. KG as a new shareholder.

January 2018 Initial studies in visceral surgery suggest that perfusion disturbances in parts of the intestine can be detected with the TIVITA® before they can be visually perceived by the physician.

September 2017 The TIVITA® Tissue is approved as a Class I medical device.

August 2017 The Diaspective Vision receives the certification for the quality management system according to 13485 after the initial audit.

June 2017 The Diaspective Vision wins the Health Industry Ideas Competition 2017 and is awarded a prize by the Minister of Economics Harry Glawe. For the first time, an extensive skin graft with a vascular connection could be saved in a study thanks to constant monitoring with the TIVITA® Tissue . This monitoring enabled the physician to determine the right time for revision in order to keep the graft alive and spare the patient further complications.

July 2016 The Diaspective Vision wins the first prize at the INNO AWARD 2016.

February 2016 Diaspective Vision takes over the entire operational business of SpekLED GmbH and welcomes two new shareholders: Keller Medical GmbH and Venture Capital Fonds MV GmbH.

July 2015 The first ERDF-funded R&D project entitled "HyperWound-CAM" is launched in cooperation with the University of Rostock and Wismar University of Applied Sciences.

May 2015 Company foundation of Diaspective Vision GmbH by Dr. Axel Kulcke.

2013 Patent application relating to a device and method for capturing a hyperspectral image (TI-CAM).

First clinical study comparing hyperspectral imaging technique with ICG fluorescein angiography

Written by Kerstin Abshagen at 25 September 2020. Published in News.

Recently, the team of Prof. Ines Gockel and PD Dr. Boris Jansen-Winkeln published for the first time in the International Journal of Colorectal Disease a comparative study of hyperspectral imaging (TIVITA^® Tissue) and fluorescence angiography (indocyanine green) for the determination of the incision margin in colorectal resections.

This prospective, human study showed that both methods visualize blood perfusion comparably well and safely, so that well perfused anastomoses can be created with their support.

We are very pleased about this publication and the positive results, which once again underline the clinical relevance and performance of hyperspectral imaging.

Source: Jansen-Winkeln B, Germann I, Köhler H, Mehdorn M, Maktabi M, Sucher R, Barberio M, Chalopin C, Diana M, Moulla Y, Gockel I. Comparison of hyperspectral imaging and fluorescence angiography for the determination of the transection margin in colorectal resections-a comparative study. Int J Colorectal Dis. 2020 Sep 23. doi: 10.1007/s00384-020-03755-z

Research project HyperLimit-CAM approved

Written by Kerstin Abshagen at 23 September 2020. Published in News.

Back at the beginning of 2019, we met with doctors from Rostock and Greifswald to discuss a potential project on amputation levels and parathyroid gland detection. It quickly became clear that this was a promising concept.

For this reason, a project was submitted to the Technology Consulting Institute in Mecklenburg-Vorpommern together with the University Medical Center Greifswald, the Südstadtklinikum Rostock and the University of Applied Sciences Wismar. Now, about one and a half years later, the first kick-off meeting for the official start of the project took place.

The project is divided into two parts:

In the first part, the amputation level in lower extremity surgeries will be assessed to minimize the error rate in such surgeries. The goal is to reduce the error rate by 50 % through hyperspectral imaging.
The second part deals with the intraoperative recognition of the parathyroid glands (NSD). During resection of thyroid tissue, complications occur again and again due to poor differentiability of both tissues. Support is to be provided here by the combination of hyperspectral and fluorescence imaging.

Many thanks to the TBI for the opportunity to implement this project. We are looking forward to the upcoming tasks and hope to further improve the clinical outcome for patients with the results.

This project is co-financed by the European Union from the European Regional Development Fund.

Hyperspectral imaging in wound medicine: A systematic review

Written by Kerstin Abshagen at 23 September 2020. Published in News.

Diaspective Vision GmbH was founded with the aim of objectifying and thus improving wound medicine. After 5 years on the market, there is an increasing awareness in medicine that there must be technologies that allow better, more objective diagnostics so that positive results can be achieved more quickly in the treatment of (chronic) wounds.

Our product TIVITA^® is already represented in many other medical applications, which are generally considered to be more important. Nevertheless, the topic of wound medicine is permanently present for us. For this reason, we are pleased that a review article on hyperspectral imaging in wound medicine was recently published for the first time and TIVITA^® is represented in it.

Source: Saiko G et al. Hyperspectral imaging in wound care: A systematic review. International Wound Journal, 2020.

Publication in "Annals of Surgery

Written by Kerstin Abshagen at 23 September 2020. Published in News.

With the publication "Hyperspectral Imaging (HSI) of Human Kidney Allografts" by Robert Sucher et al. (2020), the team succeeded in serving one of the best journals in surgery and laid the foundation for hopefully many more such projects.

The topic of transplantation medicine has only been with us for a short time, but it will become increasingly important in the future. Currently, physicians lack measurement techniques that allow an objective intraoperative assessment of the viability and performance of transplants. Since currently only the TIVITA^® is available as a measuring device for such applications, we are very pleased about this publication.

On behalf of the entire company, we would like to thank the team around PD Dr. Robert Sucher for their confidence in the HSI technology, the time invested and the great work on our TIVITA^®.

TIVITA® on Instagram

Written by Kerstin Abshagen at August 25, 2020. Published in News.

Once again a great article from the University Hospital Leipzig by Prof. Ines Gockel has been published, which supports our goal to establish HSI as a standard diagnostic.

Thanks so much for the helpful post!

Link to Instagram